Evaluate ESPR stock safety — financial health, volatility, institutional backing, and risk factors.

What are the risks of investing in ESPR? | Glauxie AI

Q: What are the risks of investing in ESPR?

Esperion Therapeutics, Inc. (ESPR) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Sheldon L. Koenig. Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product... Employees: 15,000.

Q: How much debt does ESPR have?

Review ESPR total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Q: Is ESPR a good long-term investment?

Evaluate ESPR as a long-term investment using fundamental scores, growth metrics, and risk assessment.

What are the risks of investing in ESPR?

🦉

Esperion Therapeutics, Inc. (ESPR)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOSheldon L. Koenig

Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the...

Key Executives

Name	Title
Benjamin Halladay	Chief Financial Officer
Benjamin O. Looker	Chief Legal and Corporate Affairs Officer
Betty Jean Swartz	Chief Business Officer
Glenn Brame	Chief Technical Operations Officer
John Harlow	Chief Commercial Officer
LeAnne Bloedon	Vice President & Head of Development

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

ESPR Profile Financials

Is ESPR stock safe? How much debt does ESPR have? Is ESPR a good long-term investment?